{"id":"https://genegraph.clinicalgenome.org/r/6a39b76d-8ec7-4b91-b785-2817f9457f82v1.0","type":"EvidenceStrengthAssertion","dc:description":"The TIMM8A gene has been associated with X-linked deafness dystonia syndrome (aka Mohr-TranebjÃ¦rg syndrome) using the ClinGen Clinical Validity Framework as of 8/18/2017. This association was made using case-level data and experimental data. At least 6 probands in 5 publications with at least 8 unique variants (missense, nonsense, frameshift) have been reported in humans, and variants in this gene segregated with disease in 17 additional family members (PMIDs 11803487, 22736418, 18952432, 17999202). TIMM8A was first associated with this disease in humans in 2000 (Tranebjaerg et al.). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism for disease is X-linked LOF. This gene-disease association is supported by functional alteration studies in isolated patient cells as well as non patient cells and expression studies (PMIDs: 11956200, 15254020). In summary, TIMM8A is definitively associated with X-linked deafness dystonia syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss Working Group on 12/19/2017.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/6a39b76d-8ec7-4b91-b785-2817f9457f82","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2017-12-19T05:00:00.000Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16d956ac-1d77-43e7-8681-7a36ceae63a5","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d661428c-8082-4ac8-be41-ccdb067c8339","type":"FunctionalAlteration","dc:description":"lymphoblast cell line obtained from an MTS patient in which a point mutation in the TIMM8A gene c.100>T codes for truncated p.Q34X protein, import of all substrates was severely decreased because Su9-DHFR import depends on TIMM23 biogenesis. Improper mitochondrial import is thought to lead to the pathegenesis of MTS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15254020","rdfs:label":"Q34X lymphoblast (patient) cell characterization"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/78fb9a0c-4654-4feb-9578-13a73a7f946e","type":"EvidenceLine","dc:description":"\"upgraded\" because there are two types of functional alteration being investigated here. The import ability as well as the mechanism of the loss of this ability (improper folding and TIMM13 interaction)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8e6f98c-abcf-488c-8794-c39c396e6b12","type":"FunctionalAlteration","dc:description":"Expressed mutant human DDP1C66W with hTim13 in yeast cells carrying disrupted alleles of TIM8 and TIM13. Also demonstrated that normal DDP1 and hTim13 restores yeast import to wild-type levels. They found that it was not able to restore the import functionality. They also found that the C66W missense mutation impairs the binding of Zinc via the Cys4 motif thru western blot showing that it couldn't form the higher MW complex. This is required for the stable folding of DDP1 as well as its interaction with Tim13 (Fig 9.) and therefore functionality is lost in DDP1 from this missense mutation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11956200","rdfs:label":"DDP1 p.C66W mutation"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbc53b34-a05f-408b-83e2-6e534d6a5d3f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b21e018-bcca-4ec7-8ae9-2953b13e3cf2","type":"Finding","dc:description":"Mitochondrial dysfunction generally localized to specific CNS cells causes MTS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15254020","rdfs:label":"DDP1-TIMM13 AGC Ca2+ transport","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8914d3d7-20a4-4409-84e6-06cf3d821b7a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de99a736-c892-44d2-b06f-28b1985ec69f","type":"Finding","dc:description":"In an attempt to understand the molecualar basis of MTS they investigated the expression pattern of DDP1 and TIMM13 in mouse tissues using immunoblot analysis (Fig. 1A) and in sectioned CNS using immunocytochemistry with antibodies against mammalian import components. (Fig 1B-P). Found that the most priminet expression in the soma and the dendritic portion of the Purkinje cells of the cerebellum but not in the glial cells. Expression in CNS neurons is important and consistent with disease phenotype of dystonia. they suggest that DDP1-TIMM13 function may be most important in assembly of mitochondria in the neuronal cells and that misassembly of mitochondria in a specific subset of neurons might contribute to MTS. Additionally neuronal cell loss was shown in the CNS in two unrelated families with different mutations in the DDP1/TIMMM8A locus by Tranebjaerg et al. 2001.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15254020","rdfs:label":"CNS expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac72631f-0558-4d64-b2c3-e2d68e12f3b9_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddb4a46c-b181-4aa0-b0a6-dae4d93a5955","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10878669","rdfs:label":"Tranebjaerg_1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"DNA extracted from peripheral leucocytes and cultivated fibroblasts. PCRused to detect the 233C>G substitution  by amplifying exon 2","firstTestingMethod":"PCR","phenotypeFreeText":"sensorineural hearing impairment at age 2.5 years. Mild mental retardation, normal behavior.","phenotypes":["obo:HP_0100704","obo:HP_0001268","obo:HP_0000408","obo:HP_0011463","obo:HP_0001133","obo:HP_0000613","obo:HP_0000545","obo:HP_0002015","obo:HP_0001332","obo:HP_0007663","obo:HP_0000505","obo:HP_0001257","obo:HP_0000512","obo:HP_0002659","obo:HP_0002533","obo:HP_0001419","obo:HP_0001337","obo:HP_0008596","obo:HP_0001260","obo:HP_0001347"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ac72631f-0558-4d64-b2c3-e2d68e12f3b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10878669","allele":{"id":"https://genegraph.clinicalgenome.org/r/d216fd21-59ac-4bae-8fbd-4cc07f3f1938","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004085.3(TIMM8A):c.198C>G (p.Cys66Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341082"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/de7b9b8d-a77f-46fb-9cbf-0eb8dc03f9fb_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bc78a48-f93a-481b-a8a5-b8eff33f5d89","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18952432","rdfs:label":"Aguirre_1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"detectionMethod":"Used a minisequencing test for this mutation by using the SNaPshot technology to look at variant in exon 1. Amplified by PCR.","firstTestingMethod":"PCR","phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypes":["obo:HP_0001260","obo:HP_0011463","obo:HP_0002659","obo:HP_0000545","obo:HP_0001133","obo:HP_0001257","obo:HP_0001268","obo:HP_0002015","obo:HP_0008596","obo:HP_0000613","obo:HP_0001337","obo:HP_0000408","obo:HP_0001332","obo:HP_0000505","obo:HP_0001347","obo:HP_0007663","obo:HP_0002533","obo:HP_0100704","obo:HP_0000512","obo:HP_0001419"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/de7b9b8d-a77f-46fb-9cbf-0eb8dc03f9fb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18952432","allele":{"id":"https://genegraph.clinicalgenome.org/r/543f5c66-f427-4f49-9d83-e344b4242396","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.101348532C>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413915084"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/83fbd45a-494c-4ceb-b17f-d935c6a4fe78_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Variant is de novo and null variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c78366c-c2e8-4a98-96ed-58ec9e844730","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17999202","rdfs:label":"Blesa 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"detectionMethod":"","phenotypeFreeText":"Mohr-Tranebjaerg syndrome- deafness and dystonia\n34-year-old man, had apparently normal\npsychomotor development until the age of 3 years, when\nhe was diagnosed with progressive sensorineural deafness\nattributed to an ototoxic drug. Since then, he has been\nattending a special institution for disabled people, where he\ndeveloped some rudimentary gestural and spoken language\nskills. At age 15, a progressive visual loss was noticed and\nhe was prescribed correcting glasses. At age 30, the patient\ndeveloped sudden, repeated and painful spasms on the right\nside of his neck, walking difficulties, and behavioral\nchanges, including distractability, irritability, and childish\nmanners. At this time he was admitted to a different hospital\nwhere he was diagnosed with an unspecified neurodegenerative disorder with dystonia","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/83fbd45a-494c-4ceb-b17f-d935c6a4fe78_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17999202","allele":{"id":"https://genegraph.clinicalgenome.org/r/a052eda1-7679-468f-a931-8031bb24fd4b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004085.3(TIMM8A):c.112C>T (p.Gln38Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342010"}}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d5c24fe-6ae2-4110-b72d-24c41d0794a0_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35a30cae-f27c-48e2-9cd2-e2bef4d6776b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11803487","rdfs:label":"Tranebjaerg_2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Used PCR to amplify the TIMM8a exons 1 and 2.","firstTestingMethod":"PCR","phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypes":["obo:HP_0001257","obo:HP_0007663","obo:HP_0000613","obo:HP_0001260","obo:HP_0001347","obo:HP_0002533","obo:HP_0000512","obo:HP_0000505","obo:HP_0001332","obo:HP_0001419","obo:HP_0008596","obo:HP_0011463","obo:HP_0000408","obo:HP_0002659","obo:HP_0100704","obo:HP_0001268","obo:HP_0000545","obo:HP_0002015","obo:HP_0001133","obo:HP_0001337"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2d5c24fe-6ae2-4110-b72d-24c41d0794a0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11803487","allele":{"id":"https://genegraph.clinicalgenome.org/r/90beacff-e012-44f8-b9d2-da38848cc1d6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004085.3(TIMM8A):c.116delT (p.Met39Argfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358813"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e22f9e74-59f7-4d91-8306-db4d2e061048_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a60a8b0-c677-4cff-9759-c8bf87c97186","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","rdfs:label":"Kindred A","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"detectionMethod":"Used PCR to amplify the 2 exons and surrounding intronic regions of TIMM8A.","firstTestingMethod":"PCR","phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypes":["obo:HP_0001268","obo:HP_0000545","obo:HP_0001133","obo:HP_0011463","obo:HP_0001332","obo:HP_0002015","obo:HP_0100704","obo:HP_0007663","obo:HP_0000613","obo:HP_0001257","obo:HP_0008596","obo:HP_0001337","obo:HP_0002659","obo:HP_0002533","obo:HP_0001419","obo:HP_0000408","obo:HP_0000505","obo:HP_0001260","obo:HP_0000512","obo:HP_0001347"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e22f9e74-59f7-4d91-8306-db4d2e061048_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","allele":{"id":"https://genegraph.clinicalgenome.org/r/d661215b-eb7a-4d64-8f58-ea30c6e2625a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.101346499_101346660del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645372264"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/20b53baf-2524-4617-ae6c-9d2ea4919d18_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5c8b215-76c4-4ab5-8028-9d61b161af32","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","rdfs:label":"Kindred B","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Used PCR to amplify the 2 exons and surrounding intronic regions of TIMM8A.","firstTestingMethod":"PCR","phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypes":["obo:HP_0001347","obo:HP_0001332","obo:HP_0007663","obo:HP_0000545","obo:HP_0001257","obo:HP_0100704","obo:HP_0000408","obo:HP_0008596","obo:HP_0001268","obo:HP_0001419","obo:HP_0002015","obo:HP_0011463","obo:HP_0002659","obo:HP_0001133","obo:HP_0000512","obo:HP_0000613","obo:HP_0001260","obo:HP_0001337","obo:HP_0000505","obo:HP_0002533"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/20b53baf-2524-4617-ae6c-9d2ea4919d18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","allele":{"id":"https://genegraph.clinicalgenome.org/r/b6ea03b9-8257-493f-b3ec-b9c41470ab41","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004085.3(TIMM8A):c.127delT (p.Cys43Valfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358816"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cd9173f6-a09e-41cd-8ff9-f60f81c3c6f2_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67897df5-29d8-452b-b6a6-8750bede04d1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","rdfs:label":"Kindred C","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Used PCR to amplify the 2 exons and surrounding intronic regions of TIMM8A.","firstTestingMethod":"PCR","phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypes":["obo:HP_0001337","obo:HP_0000408","obo:HP_0001347","obo:HP_0001419","obo:HP_0100704","obo:HP_0000512","obo:HP_0001260","obo:HP_0007663","obo:HP_0001133","obo:HP_0001332","obo:HP_0002659","obo:HP_0008596","obo:HP_0000545","obo:HP_0002015","obo:HP_0002533","obo:HP_0001257","obo:HP_0000505","obo:HP_0001268","obo:HP_0000613","obo:HP_0011463"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cd9173f6-a09e-41cd-8ff9-f60f81c3c6f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","allele":{"id":"https://genegraph.clinicalgenome.org/r/dc7ba1b8-ad09-4669-82ba-ea204e83e4e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.101348613G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413916279"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/a21d3842-b39e-4f98-860a-61a9aa4e2d2b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86fb2165-1727-4436-8279-119cf34e3787_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","rdfs:label":"Kindred B","family":{"id":"https://genegraph.clinicalgenome.org/r/86fb2165-1727-4436-8279-119cf34e3787","type":"Family","rdfs:label":"Kindred B","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b5c8b215-76c4-4ab5-8028-9d61b161af32"}},"phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0007663","proband":{"id":"https://genegraph.clinicalgenome.org/r/b5c8b215-76c4-4ab5-8028-9d61b161af32"}},{"id":"https://genegraph.clinicalgenome.org/r/425c16ba-05ad-48c0-9cff-cc4259e16139_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18952432","rdfs:label":"Aguirre_1","family":{"id":"https://genegraph.clinicalgenome.org/r/425c16ba-05ad-48c0-9cff-cc4259e16139","type":"Family","rdfs:label":"Aguirre_1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7bc78a48-f93a-481b-a8a5-b8eff33f5d89"}},"phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0007663","proband":{"id":"https://genegraph.clinicalgenome.org/r/7bc78a48-f93a-481b-a8a5-b8eff33f5d89"}},{"id":"https://genegraph.clinicalgenome.org/r/d1aaa63a-1bf1-4211-8830-c965b3d0dead_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11803487","rdfs:label":"Tranebjearg_2","estimatedLodScore":4.52,"family":{"id":"https://genegraph.clinicalgenome.org/r/d1aaa63a-1bf1-4211-8830-c965b3d0dead","type":"Family","rdfs:label":"Tranebjearg_2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/35a30cae-f27c-48e2-9cd2-e2bef4d6776b"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypePositiveAllelePositive":16,"phenotypes":"obo:HP_0007663","proband":{"id":"https://genegraph.clinicalgenome.org/r/35a30cae-f27c-48e2-9cd2-e2bef4d6776b"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/20bcac23-837b-4204-8cf7-b55cba357e64_proband_segregation","type":"FamilyCosegregation","dc:description":"less than 4 affected individuals.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","rdfs:label":"Kindred A","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/20bcac23-837b-4204-8cf7-b55cba357e64","type":"Family","rdfs:label":"Kindred A","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0a60a8b0-c677-4cff-9759-c8bf87c97186"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0007663","proband":{"id":"https://genegraph.clinicalgenome.org/r/0a60a8b0-c677-4cff-9759-c8bf87c97186"}},{"id":"https://genegraph.clinicalgenome.org/r/cf8236a8-053b-4ea8-9ca0-d806cdbdb3ad_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22736418","rdfs:label":"Kindred C","family":{"id":"https://genegraph.clinicalgenome.org/r/cf8236a8-053b-4ea8-9ca0-d806cdbdb3ad","type":"Family","rdfs:label":"Kindred C","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/67897df5-29d8-452b-b6a6-8750bede04d1"}},"phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0007663","proband":{"id":"https://genegraph.clinicalgenome.org/r/67897df5-29d8-452b-b6a6-8750bede04d1"}},{"id":"https://genegraph.clinicalgenome.org/r/e19f070b-848b-4988-b778-ffd251b67ccc_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10878669","rdfs:label":"Tranebjaerg_1","family":{"id":"https://genegraph.clinicalgenome.org/r/e19f070b-848b-4988-b778-ffd251b67ccc","type":"Family","rdfs:label":"Tranebjaerg_1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ddb4a46c-b181-4aa0-b0a6-dae4d93a5955"}},"phenotypeFreeText":"Mohr-Tranebjaerg syndrome: reduced visual acuity, dysarthria, progressive SNHL childhood onset, photophobia, x-linked recessive inheritance, increased susceptibility to fractures, visual impairment, hyperreflexia, abnormal electroretinogram, myopia, tremor, dystonia, dysphagia, constriction of peripheral visual field, abnormal posturing, spasticity, mental deterioration, cortical visual impairmnet, postlingual SNHL","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0007663","proband":{"id":"https://genegraph.clinicalgenome.org/r/ddb4a46c-b181-4aa0-b0a6-dae4d93a5955"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":661,"specifiedBy":"GeneValidityCriteria6","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/S2B2ZkTxxXE","type":"GeneValidityProposition","disease":"obo:MONDO_0010578","gene":"hgnc:11817","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a21d3842-b39e-4f98-860a-61a9aa4e2d2b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}